Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report released on Sunday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of DFFN stock opened at $3.01 on Friday. The business has a 50 day moving average of $3.61 and a two-hundred day moving […]
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Up 1.0 % NASDAQ:DFFN opened at $2.92 on Friday. Diffusion Pharmaceuticals has a 52 week low of $2.76 and a 52 week high of […]
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research report report published on Saturday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance DFFN opened at $2.92 on Friday. The stock has a market cap of $5.96 million, a P/E ratio of -0.38 and […]
Stock Analysts’ new coverage for Saturday, July 8th: StockNews.com initiated coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). The firm issued a sell rating on the stock. StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). They issued […]
Stock Analysts’ new coverage for Saturday, July 8th: StockNews.com initiated coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). The firm issued a sell rating on the stock. StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). They issued […]